Last week, MPS 2026, organized by the International MPS Society (iMPSS), came to a successful close.
Four days of intensive discussions, scientific exchange, and valuable networking are now behind us. We were happy to jointly demonstrate VITROCELL exposure technologies for gases, complex mixtures, and particles together with our cooperation partner AlveoliX.
By combining advanced aerosol exposure systems with organ-on-chip technology, we offer unique solutions for the direct exposure of physiologically relevant in vitro models.
The feedback we received on ongoing projects and future application requirements was extremely valuable and confirms the growing interest in advanced human-relevant testing approaches.
It was a pleasure to reconnect with so many innovators and partners from this dynamic community. We are already looking forward to MPS 2027 in Edinburgh!
